Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a decision by its board to repurchase up to HKD 30 million of its ordinary shares from the open market, indicating that the current trading price does not accurately reflect the company's intrinsic value [1] Group 1 - The board believes that the share repurchase will demonstrate confidence in the company's business outlook and prospects, ultimately benefiting the company and creating value for its shareholders [1] - The company asserts that its current financial resources are sufficient to support the proposed share repurchase while maintaining a robust financial position [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 ALPHAMAB ONCOLOGY 本公司董事（「董事」）會（「董事會」）有意宣佈，根據董事獲授出的一般授權（「股 份購回授權」，由股東於2025年6月12日舉行的股東週年大會上批准），董事會於 2025年11月7日決議不時自公開市場購回本公司普通股（「股份」），購回股份的金 額最高為30百萬港元。股份購回授權將持續有效，直至以下最早發生者為止：(i) 本公司下屆股東週年大會結束時；(ii)根據適用法律或本公司組織章程細則規定本 公司須舉行下屆股東週年大會期限屆滿時；或(iii)股東於本公司股東大會上以普 通決議案變更或撤銷該項授權時。股份購回授權的詳情載於本公司日期為2025年 5月21日的通函。 截至本公告日期，本公司根據股份購回授權購回1,681,000股股份並持作庫存股 份。股東及潛在投資者應注意，本公司之場內股份購回將視乎市況進行，並將由 董事會及╱或其授權人士全權酌情決定。概無法保證任何購回 ...

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a share buyback of 560,000 shares for a total expenditure of HKD 5.261 million on November 7, 2025, with a buyback price range of HKD 9.24 to HKD 9.52 per share [1] Summary by Category - **Company Actions** - The company executed a buyback of 560,000 shares [1] - The total amount spent on the buyback was HKD 5.261 million [1] - The buyback price per share ranged from HKD 9.24 to HKD 9.52 [1]

Group 1 - The company Corning Incorporated announced a share buyback of 560,000 shares at a total cost of HKD 5.261 million [1] - The buyback price per share ranged from HKD 9.24 to HKD 9.52 [1]

格隆汇11月7日丨康宁杰瑞制药-B(09966.HK)公告，11月7日耗资526万港元回购56万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 康寧傑瑞生物製藥 呈交日期： 2025年11月7日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 09966 | 說明 | 普通股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 康寧傑瑞生物製藥 呈交日期: 2025年11月6日 I. 法定/註冊股本變動 本月底法定/註冊股本總額： USD 50,200 FF301 第 1 頁 共 11 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09966 | 說明 | 普通股 | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | 已發行股份總數 | | | 上月底結存 | | | 971,195,697 | 2,952,000 | | 974,147,697 | | 增加 / 減少 (-) | | | -1,121,000 | 1,121,000 | | | | 本月底結存 | | | 970,0 ...

Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on October 28, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent. Group 1: Buyback Details - China Feihe (06186) repurchased 5.174 million shares for a total of 21.6293 million yuan, representing 0.209% of its total share capital [1][2] - Lianyi Rong Technology (09959) repurchased 1.4625 million shares for 4.7622 million yuan, accounting for 3.638% of its total share capital [2] - Zhongxu Future (09890) repurchased 301,400 shares for 4.4130 million yuan, which is 1.270% of its total share capital [2] Group 2: Other Notable Buybacks - Mengniu Dairy (02319) repurchased 300,000 shares for 4.2977 million yuan, representing 0.563% of its total share capital [2] - Jitu Express (01519) repurchased 385,000 shares for 3.8812 million yuan, which is 0.014% of its total share capital [2] - Kangning Jereh Pharmaceutical (09966) repurchased 320,000 shares for 3.7683 million yuan, accounting for 0.117% of its total share capital [2] Group 3: Additional Companies Involved - Other companies involved in the buyback include: - Guichuang Tongqiao-B (02190) with 50,000 shares repurchased for 1.2065 million yuan [2] - Green City Services (02869) with 208,000 shares repurchased for 969,700 yuan [2] - Tianfu (06868) with 2,000 shares repurchased for 60,400 yuan [3]

Core Viewpoint - Corning Incorporated announced a share buyback of 320,000 shares at a total cost of HKD 3.7684 million, with individual share prices ranging from HKD 11.53 to HKD 11.97 [1] Group 1 - The company plans to repurchase shares on October 28, 2025 [1] - The total expenditure for the buyback is approximately HKD 3.7684 million [1] - The price range for the repurchased shares is between HKD 11.53 and HKD 11.97 per share [1]

Core Viewpoint - Corning Pharmaceutical-B (09966.HK) announced a share buyback of 320,000 shares at a cost of HKD 3.768 million on October 28 [1] Group 1 - The company executed a buyback program, indicating a strategy to enhance shareholder value [1] - The total expenditure for the buyback was HKD 3.768 million, reflecting the company's commitment to returning capital to shareholders [1] - The number of shares repurchased was 320,000, which may influence the stock's liquidity and market perception [1]